Ossiam ETF Shiller Barclays Cape EUR Val TR 1C EUR (LCPE)

Eco Wave Power Explores AI-Powered Wave Energy Infrastructure and WaveGPT Development with Florida Atlantic University and University of MichiganJune 8, 2026 8:30 AM
PR Newswire (US) class="legendSpanClass"MIAMI, class="legendSpanClass"June 8,

OCC, there it goes

TOYO Co., Ltd. Announces Strategic Expansion into U.S. Cell Manufacturing with Planned 1.5 GW HJT Solar Cell Facility in Houston Metropolitan AreaJune 8, 2026 8:30 AM
PR Newswire (US) Co-locating cell production with existing module sit

Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental DisabilitiesJune 8, 2026 8:30 AM
PR Newswire (US)

Which one you talking about 😅

LEIFRAS Co., Ltd. Commences School Club Activity Support Operations in Niiza City, Saitama PrefectureJune 8, 2026 8:30 AM
PR Newswire (US) Spanning 29 Regional Club Activities Across Six Junior High Schools class="legendSpanClass"TOKYO,

Caris Life Sciences Announces Share Repurchase ProgramJune 8, 2026 8:30 AM
PR Newswire (US) class="legendSpanClass"IRVING, Texas, class="legendSpanClass"June 8, 2026 /PRNewswire/ -- Caris Life Sciences® (Nasdaq: CAI) ("Caris" or the "Com

MetaVia Presents New Late-Breaking Obesity and Metabolic Data at the ADA 2026 Scientific Sessions Supporting DA-1726 Differentiation and Vanoglipel Combination PotentialJune 8, 2026 8:31 AM
PR Newswire (US) DA-1726 Phase 1, 48 mg Cohort A

There is no biomarker. There will be no tissue-agnostic approval.

As the Ebola Emergency Outbreak Grows Rapidly, NanoViricides Has Proposed a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment - with Superior Oral Administration and Escape Resistance Features Over AntibodiesJune 8, 2026 8:30 AM
ACCESS Newswire

https://garywallach.substack.com/p/one-of-these-days-they-may-all-license?r=3iu9hl&utm_campaign=post&utm_medium=web&triedRedirect=true
One of These Days They May All License: Why Many Netlist (NLST) Investors Believe Persistence Could Eventually Win the Day
Gary Wallach
Jun 08,

ReElement Technologies Invited to US Chamber of Commerce's Critical Minerals SummitJune 8, 2026 8:30 AM
ACCESS NewswireFISHERS, IN / ACCESS Newswire / June 8, 2026 / American Resources C

WiMi Explores Multi-Dimensional Pooling Optimization Technology under the Variational Quantum Algorithm FrameworkJune 8, 2026 8:40 AM
PR Newswire (US) class="legendSpanClass"BEIJING, class="legendSpanClass"June 8, 2026 /PRNewswire/ -- Wi

PPG appoints John Smith to vice president, architectural coatings EMEA; Steve Pocock to retireJune 8, 2026 8:41 AM
Business Wire PPG (NYSE:PPG) today announced the appointment of John Smith to vice president, architectural coatings, EMEA, effective July 1, 2026. He will report

Good find. Thanks for posting that.

https://x.com/atwectech/status/2063960474560106739?s=46

$BTC.X Nice rebound!!! Now taking sister IDEX Crypto surges to $23 great AI developments! like RAVE did in April.. #1 next runner-up! Congrats!

You called it. We got a test I guess. LOLOLOL Nothing like what Nexboard needed to make a difference IMO.
They just couldn't PASS the more stringent NFPA 286 test. FACT!!!!!!!!!
https://investorshub.advfn.com/uimage/uploads/2026/6/8/aflujScreenshot_2026-06-08_8.37.25_AM.png
http

NEWS -- Provectus Biopharmaceuticals Announces Investor Webinar for 2026 Annual Meeting of Stockholders
https://media.zenfs.com/en/globenewswire.com/20f736654d14f584cdf9ccb4b6da3ef6
KNOXVILLE, Tenn., June 08, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or t

They are conducting about a dozen certification tests on NEXBOARD, including the 286. The "tunnel test" is actually the one most home builders care about.

Thanks. Good stuff!

Exactly this is now full steam ahead...doesn't matter what the rest say. We are on fast track forward and even EFS approval could be much quicker than the 30 day window.

Let's go ISOPET now and RDGL soon...imo

Technicals are improving with only the 20 50 and 100 day Moving Average Crossovers remaining in negative position.
Let's Go Knicks.

Copilot on whats the Delay (hopefully this has some truth to it)? i dont think i ever saw this before which sort of helps why so F'ing long for approval!
If MHRA approves DCVax L, it will be the first-ever MHRA approved cancer therapy whose pivotal evidence package relies primarily on an Ext

Global Photonics Economic Forum (GPEF) 2026, taking place 24–25 September 2026 in Málaga, Spain.

Confirmed keynote speakers

Andy Bechtolsheim, Co-Founder & Chief Architect, Arista Networks and founder of Sun Microsystems
Satish Dhanasekaran, President & CEO, Keys